Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stromal cells for SARS-CoV-2 pneumonia
RBR-8zg5rg7Withdrawn
- Sponsor
- Pontifícia Universidade Católica do Paraná
- Start
- Aug 2021
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Trial of Provacel in coronavirus disease 2019 (COVID-19) and viral pneumonia (2 arms), sponsored by Pontifícia Universidade Católica do Paraná. Planned start Aug 2021; status: withdrawn.
02
Drugs
Provacel
03
Conditions
coronavirus disease 2019 (COVID-19)viral pneumonia
Beyond the preview
Go deeper on RBR-8zg5rg7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8zg5rg7.